Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA) M Paniagua-García, JM Bravo-Ferrer, S Pérez-Galera, T Kostyanev, ... Clinical Microbiology and Infection 30 (2), 223-230, 2024 | 5 | 2024 |
Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization C Jiménez-Cortegana, E Salamanca, N Palazón-Carrión, ... Frontiers in Immunology 14, 1266659, 2023 | | 2023 |
Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae E Pérez-Nadales, M Fernández-Ruiz, AM Natera, B Gutiérrez-Gutiérrez, ... American Journal of Transplantation 23 (7), 1022-1034, 2023 | 7 | 2023 |
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study (Vol 21, pg 783, 2021) B Gutierrez-Gutierrez, MD del Toro, A Borobia LANCET INFECTIOUS DISEASES 23 (6), E198-E198, 2023 | | 2023 |
Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of … V Pintado, P Ruiz-Garbajosa, D Aguilera-Alonso, F Baquero-Artigao, ... Enfermedades infecciosas y microbiologia clinica (English ed.) 41 (6), 360-370, 2023 | 14 | 2023 |
Pharmacological therapy in the secondary prevention of ischemic stroke in the oldest-old patients: has it improved in recent decades? L Castilla-Guerra, MC Fernández-Moreno, ML González-Iglesias, ... Revista Clínica Española (English Edition) 223 (4), 202-208, 2023 | | 2023 |
Terapia farmacológica en la prevención secundaria del ictus isquémico en los muy ancianos:¿ ha mejorado en las últimas décadas? L Castilla-Guerra, MC Fernández-Moreno, ML González-Iglesias, ... Revista Clínica Española 223 (4), 202-208, 2023 | | 2023 |
Role of IP-10 to predict clinical progression and response to IL-6 blockade with Sarilumab in early COVID-19 pneumonia. A subanalysis of the SARICOR clinical trial M Trigo-Rodríguez, S Cárcel, A Navas, R Espíndola-Gómez, ... Open Forum Infectious Diseases 10 (4), ofad133, 2023 | | 2023 |
Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA) S Pérez-Galera, JM Bravo-Ferrer, M Paniagua, T Kostyanev, ... EClinicalMedicine 57, 2023 | 24 | 2023 |
Opening a DOOR for pivotal studies: an example for complicated urinary tract infections J Rodríguez-Baño, B Gutiérrez-Gutiérrez Clinical Infectious Diseases 76 (3), e1166-e1167, 2023 | 1 | 2023 |
Conventional Hospitalization versus Sequential Outpatient Parenteral Antibiotic Therapy for Staphylococcus aureus Bacteremia: Post-Hoc Analysis of a Multicenter … N Castillo-Fernández, PMM Pérez-Crespo, E Salamanca-Rivera, ... Antibiotics 12 (1), 129, 2023 | 1 | 2023 |
Resumen ejecutivo del documento de consenso de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC) sobre el diagnóstico y tratamiento … V Pintado, P Ruiz-Garbajosa, D Aguilera-Alonso, F Baquero-Artigao, ... Enfermedades Infecciosas y Microbiología Clínica 41 (6), 360-370, 2023 | | 2023 |
IP-10 Predicts Clinical Progression and Response to IL-6 Blockade with Sarilumab in Early COVID-19 Pneumonia. The SARICOR Clinical Trial M Trigo-Rodriguez, S Cárcel, A Navas, R Espíndola-Gómez, ... | | 2022 |
Prognostic significance of the relative load of KPC-producing Klebsiella pneumoniae within the intestinal microbiota in a prospective cohort of colonized patients E Pérez-Nadales, A M. Natera, M Recio-Rufián, J Guzmán-Puche, ... Microbiology Spectrum 10 (4), e02728-21, 2022 | 5 | 2022 |
Extended‐spectrum β‐lactamase‐producing and carbapenem‐resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and … E Pérez‐Nadales, M Fernández‐Ruiz, B Gutiérrez‐Gutiérrez, Á Pascual, ... Transplant Infectious Disease 24 (4), e13881, 2022 | 6 | 2022 |
Association between rectal colonisation by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae and mortality: a prospective, observational study Á Cano, B Gutiérrez-Gutiérrez, I Machuca, J Torre-Giménez, ... Journal of Global Antimicrobial Resistance 29, 476-482, 2022 | 8 | 2022 |
Association between timing of colonization and risk of developing Klebsiella pneumoniae carbapenemase-producing K. pneumoniae infection in hospitalized patients Á Cano, B Gutiérrez-Gutiérrez, I Machuca, J Torre-Giménez, ... Microbiology Spectrum 10 (2), e01970-21, 2022 | 10 | 2022 |
Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial J Molina, E Montero-Mateos, J Praena-Segovia, E León-Jiménez, ... Clinical Microbiology and Infection 28 (4), 550-557, 2022 | 88 | 2022 |
Clinical outcomes of an innovative cefazolin delivery program for MSSA infections in OPAT L Herrera-Hidalgo, R Luque-Márquez, A de Alarcon, AB Guisado-Gil, ... Journal of Clinical Medicine 11 (6), 1551, 2022 | 3 | 2022 |
Immunoguided discontinuation of prophylaxis for cytomegalovirus disease in kidney transplant recipients treated with antithymocyte globulin: a randomized clinical trial A Páez-Vega, B Gutiérrez-Gutiérrez, ML Agüera, C Facundo, ... Clinical Infectious Diseases 74 (5), 757-765, 2022 | 29 | 2022 |